Research summaries for everyoneNot medical advice
Skin & Collagen research area, Elevated Pharma

Research area

Skin & Collagen

Copper-peptide and melanocortin-fragment research in skin, collagen and inflammation models.

2 references12 key studies

Skin & Collagen references

Research updates

Recent developments

The latest dated changes for skin & collagen references. See all research updates.

  1. HHS interim compounding policy

    HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.

    Read the source
  2. Expert caution on clinical claims

    A commentary in Aesthetic Surgery Journal warns that mechanistic plausibility is not clinical validation.

    Read the source
  3. FDA advisory committee votes

    FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).

    Read the source
  4. Category 2 removals

    FDA announced the removal of 12 peptide substances from its Category 2 compounding list, effective about April 22, 2026. Removal is not approval.

    Read the source